Leef Brands (LEEEF) Gross Margin (2025 - 2026)
Leef Brands (LEEEF) posted Gross Margin of 49.32% for Q1 2026, up 123.56% sequentially from 22.06% in Q1 2025, and up 2726.0% YoY from 1.75% in Q1 2025.
Leef Brands (LEEEF) Gross Margin (2025 - 2026) Analysis & Trends
Leef Brands has reported Gross Margin for 2 years, with the latest figure at 49.32% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn | 33.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.13% |
| Mar 31, 2026 | 49.32% |
| Mar 31, 2025 | 22.06% |